Bolivia Medical Device Regulatory Horizon Scanning 2025–2027: ATT, MERCOSUR and AGEMED Signals

1. Key takeaways

Three changes have had the greatest impact on medical device companies in Bolivia in the past two years. First, ATT published the list of telecommunication equipment subject to type approval on 28 January 2026 and updated it on 25 February 2026, adding LoRaWAN, RFID, SRD, and FM/AM receivers, and ceasing to issue declarations that approval is not required. Second, Bolivia became a full member of MERCOSUR effective 8 July 2024, and must absorb the existing regulatory acquis within four years, with GMC Resolution N° 25/21 the core transmission variable on the device side. Third, the AGEMED weekly bulletin continuously publishes registration decisions, and the practical estimate compiled by GRZAN shows an observation rate of approximately 44.4 percent, giving companies a quantifiable benchmark for dossier quality. GRZAN recommends concentrating tracking resources over the next twenty-four months on these three lines, because each line moves on its own clock and none of them waits for the others.

The three lines interact in ways worth planning for. The ATT line is national, technical, and already binding; the MERCOSUR line is supranational and will reshape documentation formats over years; the weekly bulletin line is informational and turns both of the others into measurable signals. A company that treats them as one undifferentiated regulatory noise stream will act too late on the first and too early on the second. The tracking list in the recommendations below is built to prevent exactly that, assigning each line its own review cadence and its own owner, and the checklist at the end of this article converts the list into verifiable records rather than good intentions.

2. Legal basis

3. Expert insights

Insight one: the change already in force is the ATT list, and its impact is immediate. Any product containing a wireless module must now pass type approval, with no exemption channel, and the approval sits outside AGEMED jurisdiction while remaining a precondition for customs clearance. This is where companies most often miss a requirement, because the obligation belongs to a different regulatory family from the sanitary registration and therefore never appears in registration checklists. A device with an embedded Bluetooth or LoRa module that has cleared AGEMED can still be stopped at the border for missing homologation. Project schedules should therefore place the type approval application in parallel with the sanitary registration, not after it, since the approval timelines are independent and a serial plan wastes the overlap.

Insight two: the change not yet in force but counting down is the MERCOSUR absorption window. The four-year period runs from July 2024, placing the window around mid-2028, and the volume awaiting absorption is approximately 3,974 regulatory measures and 84 agreements. This does not change the current basis for submissions, but new documentation format requirements will be transmitted to the Manual over the window. The correct response is modular documentation, not premature format conversion: keep the dossier in blocks that can be re-skinned when the transposition instruments arrive.

Insight three: the change that can be observed continuously is the weekly bulletin data. AGEMED publishes decisions weekly, an unusually quantifiable signal source for the region. GRZAN recommends treating the bulletin as a standing source of competitive and compliance intelligence rather than a one-time search before submitting, because the distribution of observation reasons shifts over time and each shift tells companies where their own dossiers are most exposed. Reading the bulletin quarterly, recording the count of decisions and observations, and comparing the trend against the 44.4 percent practical estimate turns a public document into a private benchmark at almost no cost.

4. Practical recommendations

GRZAN provides the following twenty-four-month tracking list, ordered by priority:

1. Any update to the ATT list of equipment subject to approval, including whether a category specific to medical devices is added.
2. Transposition documents for GMC Resolution N° 25/21 in Bolivia, watching for related resolutions issued by AGEMED or the Ministry of Foreign Affairs.
3. Version updates of the Manual, checked against the current version of R.M. N° 010.
4. The current operative text of the R.M. N° 0265 fee schedule.
5. The distribution of observation reasons in the AGEMED weekly bulletin, used to update the documentary baseline of the company.
6. Publication of a device-specific vigilance document, following through on the dynamics of R.M. N° 1110 as cited by Circular 37-2025.

Each line on the list has an owner, a cadence, and an evidence rule. The ATT line is reviewed monthly, because list updates arrive without much warning and affect clearance directly. The MERCOSUR line is reviewed quarterly, since transposition instruments move slowly but carry large consequences when they land. The bulletin line is reviewed quarterly against the running observation tally. Every review ends with one of three recorded outcomes: no change, change recorded with the source document attached, or action opened. This discipline is what separates horizon scanning from news reading, and it is the difference GRZAN builds into every regulatory monitoring plan it maintains for clients in the region.

5. Verification checklist

• □ Have the ATT list update dates and the added categories been recorded?
• □ Have the start and end of the MERCOSUR absorption window been entered into planning assumptions?
• □ Has the transposition status of GMC Resolution N° 25/21 been set as a quarterly query item?
• □ Have the current versions of the Manual and the fee schedule been downloaded and archived?
• □ Is the weekly bulletin search mechanism running on a routine basis?

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers, and authorized representatives with sanitary registration, regulatory horizon scanning, and post-market compliance in Bolivia. For assistance with this topic, contact info@grzanglobal.com.